HAG
COCH icon

HighPoint Advisor Group’s Envoy Medical COCH Stock Holding History

HighPoint Advisor Group’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,662
Closed -$30K – 1079
2025
Q3 		$30K Hold
38,662
– – ﹤0.01% 686
2025
Q2 		$54.9K Hold
38,662
– – ﹤0.01% 671
2025
Q1 		$54.1K Hold
38,662
– – ﹤0.01% 646
2024
Q4 		$56.8K Hold
38,662
– – ﹤0.01% 662
2024
Q3 		$98.6K Buy
+38,662
New +$105K 0.01% 647

Other funds holding COCH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighPoint Advisor Group's COCH Position: Q4 2025 in Review

HighPoint Advisor Group sold out of Envoy Medical (COCH) in Q4 2025, closing a stake of 38,662 shares — an estimated $30K sold.

HighPoint Advisor Group first reported a position in COCH in Q3 2024 and held it in 5 quarters. The position peaked at $98.6K in Q3 2024. 27 funds tracked by Wall St. Rank hold COCH as of Q4 2025.

  • HighPoint Advisor Group reported no remaining Envoy Medical position as of Q4 2025 after selling out during the quarter.
  • HighPoint Advisor Group sold 38,662 Envoy Medical shares in Q4 2025, an estimated $30K.
  • HighPoint Advisor Group first reported a position in Envoy Medical in Q3 2024 and held it in 5 quarters.
  • HighPoint Advisor Group's Envoy Medical position peaked at $98.6K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2025.

Based on HighPoint Advisor Group's 13F filing for Q4 2025, filed 4 Feb 2026.